Close Menu

NEW YORK (GenomeWeb) – The Wyss Institute for Biologically Inspired Engineering at Harvard University and Cellectis announced today that they will collaborate on a project that the Wyss has undertaken to recode the genome of cell lines derived from humans and other species, and to develop new tools and methods to achieve that goal.

The cell lines would be engineered to resist debilitating viral infections while carrying out their normal functions, or even perform entirely new functions, the Wyss said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.